Evidence map›Paper›PMID 32513393›Full record

Observational studyActas dermo-sifiliograficas2020

[Estimated Effect of COVID-19 Lockdown on Skin Tumor Size and Survival: An Exponential Growth Model].

A Tejera-Vaquerizo, J Cañueto, A Toll, J Santos-Juanes, A Jaka, C Ferrandiz-Pulido, O Sanmartín, S Ribero, D Moreno-Ramírez, F Almazán and 3 more

Open access · goldAbstract readMulticenter StudyObservational Study
In one paragraph

Observational study in Actas dermo-sifiliograficas, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
3.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 31 citations in OpenAlex.

  1. Cutaneous mast cell tumors in dogs: Association with gonadectomy.Brazilian journal of veterinary medicine · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Melanomversorgung während eines Jahres Pandemie in Berlin: abnehmende Terminstornierungen trotz zunehmender Besorgnis über COVID-19.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2022
    Article
  9. Melanoma care during one year pandemic in Berlin: decreasing appointment cancellations despite increasing COVID-19 concern.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 8 institutions in 1 country.

A Tejera-VaquerizoServicio de Dermatología, Instituto Dermatológico GlobalDerm, Palma del Río, Córdoba, España. Electronic address: antoniotejera@aedv.es.
J CañuetoServicio de Dermatología, Hospital Universitario de Salamanca, Salamanca, España.
A TollServicio de Dermatología, Hospital Clìnic de Barcelona, Barcelona, España.
J Santos-JuanesServicio de Dermatología, Hospital Universitario Central de Asturias, Oviedo, Asturias, España.
A JakaServicio de Dermatología, Hospital Germans Trial i Pujol, Badalona, Barcelona, España.
C Ferrandiz-PulidoServicio de Dermatología, Hospital Universitario Vall d'Hebron, Barcelona, España.
O SanmartínServicio de Dermatología, Instituto Valenciano de Oncología, Valencia, España.
S RiberoDepartamento de Dermatología, Hospital Universitario de Turín, Turín, Italia.
D Moreno-RamírezUnidad de Melanoma, Servicio de Dermatología Médico-Quirúrgica, Hospital Universitario Virgen Macarena, Sevilla, España.
F AlmazánUnidad de Gestión Clínica de Dermatología, Hospital Universitario San Cecilio, Granada, España.
M J FuenteServicio de Dermatología, Hospital Germans Trial i Pujol, Badalona, Barcelona, España.
S PodlipnikServicio de Dermatología, Hospital Clìnic de Barcelona, Barcelona, España.
E NagoreServicio de Dermatología, Instituto Valenciano de Oncología, Valencia, España.
Fundación Instituto Valenciano de Oncología · ESHospital Clínic de Barcelona · ESHospital Universitari Germans Trias i Pujol · ESComplejo Hospitalario de Salamanca · ESHospital Universitario Central de Asturias · ESHospital Universitario Virgen Macarena · ESInstituto de Investigación Biosanitaria de Granada · ESVall d'Hebron Hospital Universitari · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND AND

objectivesSpain is in a situation of indefinite lockdown due to the ongoing coronavirus disease 2019 (COVID-19) pandemic. One of the consequences of this lockdown is delays in medical and surgical procedures for common diseases. The aim of this study was to model the impact on survival of tumor growth caused by such delays in patients with squamous cell carcinoma (SCC) and melanoma. MATERIAL AND

methodsMulticenter, retrospective, observational cohort study. We constructed an exponential growth model for both SCC and melanoma to estimate tumor growth between patient-reported onset and surgical excision at different time points.

resultsData from 200 patients with SCC of the head and neck and 1000 patients with cutaneous melanoma were included. An exponential growth curve was calculated for each tumor type and we estimated tumor size after 1, 2, and 3 months of potential surgical delay. The proportion of patients with T3 SCC (diameter >4cm or thickness >6 mm) increased from 41.5% (83 patients) in the initial study group to an estimated 58.5%, 70.5%, and 72% after 1, 2, and 3 months of delay. Disease-specific survival at 2, 5, and 10 years in patients whose surgery was delayed by 3 months decreased by 6.2%, 8.2%, and 5.2%, respectively. The proportion of patients with ultrathick melanoma (>6 mm) increased from 6.9% in the initial study group to 21.9%, 30.2%, and 30.2% at 1, 2, and 3 months. Five- and 10-year disease-specific survival both decreased by 14.4% in patients treated after a potential delay of 3 months.

conclusionsIn the absence of adequate diagnosis and treatment of SCC and melanoma in the current lockdown situation in Spain, we can expect to see to a considerable increase in large and thick SCCs and melanomas. Efforts must be taken to encourage self-examination and facilitate access to dermatologists in order to prevent further delays.

Indexed as

BetacoronavirusTumor BurdenAge FactorsAlgorithmsCarcinoma, Squamous CellCoronavirus InfectionsCOVID-19Delayed DiagnosisFemaleHead and Neck NeoplasmsHealth Services AccessibilityHumansMaleMelanomaPandemicsPneumonia, ViralCOVID-19 virus diseaseCutaneous squamous cell carcinomaEarly diagnosisLockdownMelanomaPrognosis

Identifiers

PMID32513393
PMCPMC7211725
OpenAlexW3023932367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.